136 related articles for article (PubMed ID: 16750184)
41. Central role for ornithine decarboxylase in beta-adrenoceptor mediated hypertrophy.
Schlüter KD; Frischkopf K; Flesch M; Rosenkranz S; Taimor G; Piper HM
Cardiovasc Res; 2000 Jan; 45(2):410-7. PubMed ID: 10728361
[TBL] [Abstract][Full Text] [Related]
42. Regulation of swelling-activated Cl(-) current by angiotensin II signalling and NADPH oxidase in rabbit ventricle.
Ren Z; Raucci FJ; Browe DM; Baumgarten CM
Cardiovasc Res; 2008 Jan; 77(1):73-80. PubMed ID: 18006461
[TBL] [Abstract][Full Text] [Related]
43. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils.
Chen LW; Lin MW; Hsu CM
J Biomed Sci; 2005; 12(2):311-9. PubMed ID: 15917990
[TBL] [Abstract][Full Text] [Related]
44. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
[TBL] [Abstract][Full Text] [Related]
45. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
Baliga RR; Pimental DR; Zhao YY; Simmons WW; Marchionni MA; Sawyer DB; Kelly RA
Am J Physiol; 1999 Nov; 277(5):H2026-37. PubMed ID: 10564160
[TBL] [Abstract][Full Text] [Related]
46. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy.
Watkins SJ; Jonker L; Arthur HM
Cardiovasc Res; 2006 Feb; 69(2):432-9. PubMed ID: 16360132
[TBL] [Abstract][Full Text] [Related]
47. Cocaine produces cardiac hypertrophy by protein kinase C dependent mechanisms.
Henning RJ; Li Y
J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):149-60. PubMed ID: 12808488
[TBL] [Abstract][Full Text] [Related]
48. Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.
Xu Q; Dalic A; Fang L; Kiriazis H; Ritchie RH; Sim K; Gao XM; Drummond G; Sarwar M; Zhang YY; Dart AM; Du XJ
Br J Pharmacol; 2011 Mar; 162(5):1012-28. PubMed ID: 20955367
[TBL] [Abstract][Full Text] [Related]
49. alpha1B-Adrenergic receptor phosphorylation and desensitization induced by transforming growth factor-beta.
Romero-Avila MT; Flores-Jasso CF; García-Sáinz JA
Biochem J; 2002 Dec; 368(Pt 2):581-7. PubMed ID: 12234252
[TBL] [Abstract][Full Text] [Related]
50. Signal-transduction pathways involved in the hypertrophic effect of hsp56 in neonatal cardiomyocytes.
Jamshidi Y; Zourlidou A; Carroll CJ; Sinclair J; Latchman DS
J Mol Cell Cardiol; 2004 Mar; 36(3):381-92. PubMed ID: 15010277
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of Mid-chain HETEs Protects Against Angiotensin II-induced Cardiac Hypertrophy.
Elkhatali S; Maayah ZH; El-Sherbeni AA; Elshenawy OH; Abdelhamid G; Shoieb SM; El-Kadi AOS
J Cardiovasc Pharmacol; 2017 Jul; 70(1):16-24. PubMed ID: 28437282
[TBL] [Abstract][Full Text] [Related]
52. Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms.
Kim JK; Pedram A; Razandi M; Levin ER
J Biol Chem; 2006 Mar; 281(10):6760-7. PubMed ID: 16407188
[TBL] [Abstract][Full Text] [Related]
53. Role of NF-κB and p38 MAPK activation in mediating angiotensin II and endothelin-1-induced stimulation in leptin production and cardiomyocyte hypertrophy.
Rajapurohitam V; Kilic A; Javadov S; Karmazyn M
Mol Cell Biochem; 2012 Jul; 366(1-2):287-97. PubMed ID: 22527934
[TBL] [Abstract][Full Text] [Related]
54. Differential regulation of phospholipase C-beta isozymes in cardiomyocyte hypertrophy.
Schnabel P; Mies F; Nohr T; Geisler M; Böhm M
Biochem Biophys Res Commun; 2000 Aug; 275(1):1-6. PubMed ID: 10944430
[TBL] [Abstract][Full Text] [Related]
55. Zinc induces mitogen-activated protein kinase activation mediated by reactive oxygen species in rice roots.
Lin CW; Chang HB; Huang HJ
Plant Physiol Biochem; 2005; 43(10-11):963-8. PubMed ID: 16324848
[TBL] [Abstract][Full Text] [Related]
56. Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.
Correa MV; Nolly MB; Caldiz CI; de Cingolani GE; Cingolani HE; Ennis IL
Pflugers Arch; 2014 Sep; 466(9):1819-30. PubMed ID: 24327206
[TBL] [Abstract][Full Text] [Related]
57. SGK1 is involved in cardioprotection of urocortin-1 against hypoxia/reoxygenation in cardiomyocytes.
Cong B; Wang L; Zhu X; Li X; Liu B; Ni X
Can J Cardiol; 2014 Jun; 30(6):687-95. PubMed ID: 24882544
[TBL] [Abstract][Full Text] [Related]
58. Cross-talk between MAPKs and PI-3K pathways alters the functional density of I(K) channels in hypertrophied hearts.
Zhao A; Alvin Z; Laurence G; Li C; Haddad GE
Ethn Dis; 2010; 20(1 Suppl 1):S1-219-24. PubMed ID: 20521419
[TBL] [Abstract][Full Text] [Related]
59. Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling.
Xu L; Su Y; Yang X; Bai X; Wang Y; Zhuo C; Meng Z
Phytomedicine; 2023 Jun; 114():154779. PubMed ID: 37023527
[TBL] [Abstract][Full Text] [Related]
60. Angiotensin II affects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes.
Kim N; Jung Y; Nam M; Sun Kang M; Lee MK; Cho Y; Choi EK; Hwang GS; Soo Kim H
Sci Rep; 2017 Sep; 7(1):10328. PubMed ID: 28871102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
